Programmed death-ligand 1 expression in diffuse large B-cell lymphoma is associated with poor prognosis.

Al-Khateeb, Esraa; Abbas, Manal A; Khader, Majd B; Sughayer, Maher A

Al-Khateeb, Esraa; Abbas, Manal A; Khader, Majd B; Sughayer, Maher A.

Afiliação

Al-Khateeb E; Department of Pathology and Laboratory Medicine, 37559King Hussein Cancer Center, Amman, Jordan.
Abbas MA; Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman, Jordan.
Khader MB; Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman, Jordan.
Sughayer MA; Pharmacological and Diagnostic Research Lab., 108573Al-Ahliyya Amman University, Amman, Jordan.

Int J Biol Markers ; 38(1): 53-60, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36617986

Assuntos

Antígeno B7-H1; Linfoma Difuso de Grandes Células B; Humanos; Masculino; Feminino; Biomarcadores Tumorais/metabolismo; Linfoma Difuso de Grandes Células B/genética; Linfoma Difuso de Grandes Células B/metabolismo; Prognóstico

Palavras-chave

Combined positive score; DLBCL; PD-L1; event-free survival; immunohistochemistry; tumor proportional score

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Antígeno B7-H1 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Int J Biol Markers Assunto da revista: BIOQUIMICA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Jordânia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google